脉冲场消融治疗持续性心房颤动
PersAFOne 单臂研究评估双相双极脉冲场消融(PFA)在持续性心房颤动(AF)患者中行肺静脉隔离(PVI)和左房后壁(LAPW)消融的安全性与病灶持久性。25 例患者中急性 PVI 和 LAPW 消融均 100% 成功,侵入性再标测显示 96% 肺静脉和 100% LAPW 实现持久隔离,无食管黏膜损伤或肺静脉狭窄。
要点
- PFA 可高效安全地完成持续性 AF 的 PVI 和 LAPW 消融。
- 侵入性再标测显示肺静脉和 LAPW 病灶持久隔离率高。
- 术后未观察到食管黏膜损伤或肺静脉狭窄。
核心结论
- PFA 的安全特性使其能够高效、安全且持久地完成 PVI 和 LAPW 消融,将 PFA 的潜在应用从阵发性 AF 扩展至持续性 AF。
研究设计与样本
- PersAFOne 为单臂研究,评估双相双极 PFA 使用多分支导管在腔内超声心动图引导下行 PVI 和 LAPW 消融,共纳入 25 例患者,并在术后 2 至 3 个月强制进行侵入性再标测以评估病灶持久性。
主要发现
- 25 例患者中,仅使用多分支 PFA 导管即实现急性 PVI 成功(96/96 肺静脉;平均消融时间 22 分钟,IQR 15–29 分钟)和 LAPW 消融成功(24/24 患者;中位消融时间 10 分钟,IQR 6–13 分钟)。
- 使用局灶 PFA 导管在 13/13 患者中实现急性三尖瓣峡部阻滞(中位时间 9 分钟,IQR 6–12 分钟)。
- 中位总手术时间 125 分钟(IQR 108–166 分钟),其中电压标测中位 28 分钟(IQR 25–33 分钟),中位透视时间 16 分钟(IQR 12–23 分钟)。
- 术后食管胃十二指肠镜和重复心脏计算机断层扫描分别未发现黏膜病变和肺静脉狭窄。
- 侵入性再标测显示,使用五分支导管治疗的 85 条肺静脉中 82 条(96%)和 21 个 LAPW 中 21 个(100%)实现持久隔离(以入口阻滞定义);3 例患者 LAPW 消融部位出现局限性瘢痕消退,但无传导突破。
临床怎么用
- 对于持续性 AF 患者,可考虑使用 PFA 行 PVI 联合 LAPW 消融,以实现高效、安全且持久的病灶隔离。
- 术中可结合腔内超声心动图引导,无需食管保护策略。
- 术后可通过侵入性再标测评估病灶持久性,但需结合临床实际选择。
局限性
- 本研究为单臂研究,样本量较小(25 例),缺乏对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unlike for paroxysmal atrial fibrillation (AF), pulmonary vein isolation (PVI) alone is considered insufficient for many patients with persistent AF. Adjunctive ablation of the left atrial posterior wall (LAPW) may improve outcomes, but is limited by both the difficulty of achieving lesion durability and concerns of damage to the esophagus-situated behind the LAPW. OBJECTIVES: This study sought to assess the safety and lesion durability of pulsed field ablation (PFA) for both PVI and LAPW ablation in persistent AF. METHODS: PersAFOne is a single-arm study evaluating biphasic, bipolar PFA using a multispline catheter for PVI and LAPW ablation under intracardiac echocardiographic guidance. A focal PFA catheter was used for cavotricuspid isthmus ablation. No esophageal protection strategy was used. Invasive remapping was mandated at 2 to 3 months to assess lesion durability. RESULTS: In 25 patients, acute PVI (96 of 96 pulmonary veins [PVs]; mean ablation time: 22 min; interquartile range [IQR]: 15 to 29 min) and LAPW ablation (24 of 24 patients; median ablation time: 10 min; IQR: 6 to 13 min) were 100% acutely successful with the multispline PFA catheter alone. Using the focal PFA catheter, acute cavotricuspid isthmus block was achieved in 13 of 13 patients (median: 9 min; IQR: 6 to 12 min). The median total procedure time was 125 min (IQR: 108 to 166 min) (including a median of 28 min [IQR: 25 to 33 min] for voltage mapping), with a median of 16 min (IQR: 12 to 23 min) fluoroscopy. Post-procedure esophagogastroduodenoscopy and repeat cardiac computed tomography revealed no mucosal lesions or PV narrowing, respectively. Invasive remapping demonstrated durable isolation (defined by entrance block) in 82 of 85 PVs (96%) and 21 of 21 LAPWs (100%) treated with the pentaspline catheter. In 3 patients, there was localized scar regression of the LAPW ablation, albeit without conduction breakthrough. CONCLUSIONS: The unique safety profile of PFA potentiated efficient, safe, and durable PVI and LAPW ablation. This extends the potential role of PFA beyond paroxysmal to persistent forms of AF. (Pulsed Fields for Persistent Atrial Fibrillation [PersAFOne]; NCT04170621).
引用
- Reddy VY, Anic A, Koruth J, et al. Pulsed Field Ablation in Patients With Persistent Atrial Fibrillation. J Am Coll Cardiol. 2020. PMID: 32854842. doi:10.1016/j.jacc.2020.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。